SILO PHARMA, INC. Accumulated Other Comprehensive Income
SILO PHARMA, INC. (SILO) had Accumulated Other Comprehensive Income of $6.83 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.83K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.72K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.83K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $11.35K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $6.83K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.72K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.83K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $11.35K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $9.56K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $10.70K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.42K POS AM · filed 2026-04-14 |
| 2024-09-30 | $19.80K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $8.03K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $26.10K 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$6.23K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$723.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$3.28K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $5.24K 10-Q · filed 2023-05-12 |
| 2017-12-31 | -$470.39K 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |